Literature DB >> 3321606

The definition of ABO factors in transplantation: relation to other humoral antibody states.

T E Starzl1, A Tzakis, L Makowka, B Banner, A Demetrius, G Ramsey, R Duquesnoy, M Griffin.   

Abstract

The first examples of hyperacute rejection of renal hemografts were seen almost 25 years ago when kidneys were transplanted to ABO incompatible recipients whose plasma contained antigraft isoagglutinins. Hyperacute rejection caused in sensitized recipients by lymphocytotoxic antibodies is similar in that the immune reaction triggers an acute inflammatory reaction that leads to widespread thrombotic occlusion and devascularization of the graft. The events after xenotransplantation between certain species are essentially the same. Potential strategies to avoid the precipitating antigen antibody reaction or to mitigate the resulting effector cascade are described.

Entities:  

Mesh:

Substances:

Year:  1987        PMID: 3321606      PMCID: PMC2987702     

Source DB:  PubMed          Journal:  Transplant Proc        ISSN: 0041-1345            Impact factor:   1.066


  26 in total

1.  Clinical and immunological alterations observed in patients undergoing long-term thoracic duct drainage.

Authors:  H I Machleder; H Paulus
Journal:  Surgery       Date:  1978-07       Impact factor: 3.982

2.  Hyperacute rejection of kidney allografts, associated with pre-existing humoral antibodies against donor cells.

Authors:  F Kissmeyer-Nielsen; S Olsen; V P Petersen; O Fjeldborg
Journal:  Lancet       Date:  1966-09-24       Impact factor: 79.321

3.  Humoral antibodies and coagulation mechanisms in the accelerated or hyperacute rejection of renal homografts in sensitized canine recipients.

Authors:  K M Simpson; D L Bunch; H Amemiya; H J Boehmig; C B Wilson; F J Dixon; A J Coburg; W E Hathaway; G R Giles; T E Starzl
Journal:  Surgery       Date:  1970-07       Impact factor: 3.982

4.  "Hyperacute" renal-homograft rejection in man.

Authors:  G M Williams; D M Hume; R P Hudson; P J Morris; K Kano; F Milgrom
Journal:  N Engl J Med       Date:  1968-09-19       Impact factor: 91.245

5.  Modification of xenograft response by selective plasmapheresis.

Authors:  F K Merkel; M Bier; C D Beavers; W G Merriman; C Wilson; T E Starzl
Journal:  Transplant Proc       Date:  1971-03       Impact factor: 1.066

6.  Selective plasmapheresis in dogs for delay of heterograft response.

Authors:  M Bier; C D Beavers; W G Merriman; F K Merkel; B Eiseman; T Z Starzl
Journal:  Trans Am Soc Artif Intern Organs       Date:  1970

7.  Significance of the positive crossmatch test in kidney transplantation.

Authors:  R Patel; P I Terasaki
Journal:  N Engl J Med       Date:  1969-04-03       Impact factor: 91.245

8.  Shwartzman reaction after human renal homotransplantation.

Authors:  T E Starzl; R A Lerner; F J Dixon; C G Groth; L Brettschneider; P I Terasaki
Journal:  N Engl J Med       Date:  1968-03-21       Impact factor: 91.245

9.  Erythrocytes in human transplantation: effects of pretreatment with ABO group-specific antigens.

Authors:  F T Rapaport; J Dausset; L Legrand; A Barge; H S Lawrence; J M Converse
Journal:  J Clin Invest       Date:  1968-10       Impact factor: 14.808

10.  Modification of hyperacute canine renal homograft and pig-to-dog heterograft rejection by the intra-arterial infusion of citrate.

Authors:  M Kux; H J Boehmig; H Amemiya; M Torisu; T Yokoyama; B Launois; M Popovtzer; C B Wilson; F J Dixon; T E Starzl
Journal:  Surgery       Date:  1971-07       Impact factor: 3.982

View more
  15 in total

1.  Preformed lymphocytotoxic antibodies: the effects of class, titer and specificity on liver vs. heart allografts.

Authors:  T Furuya; N Murase; K Nakamura; J Woo; S Todo; A J Demetris; T E Starzl
Journal:  Hepatology       Date:  1992-12       Impact factor: 17.425

2.  Human liver xenotransplantation.

Authors:  T E Starzl; A Tzakis; J J Fung; S Todo; I R Marino; A J Demetris
Journal:  Xeno       Date:  1993-09

3.  The Future of Xenotransplantation.

Authors:  Thomas E Starzl
Journal:  Ann Surg       Date:  1992-10-01       Impact factor: 12.969

Review 4.  Liver transplantation (1).

Authors:  T E Starzl; A J Demetris; D Van Thiel
Journal:  N Engl J Med       Date:  1989-10-12       Impact factor: 91.245

5.  Transplantation: the realization of a dream.

Authors:  T E Starzl
Journal:  Semin Nucl Med       Date:  1988-07       Impact factor: 4.446

6.  Reduction of primary nonfunction with prostaglandin E1 after clinical liver transplantation.

Authors:  S Takaya; H Doyle; S Todo; W Irish; J J Fung; T E Starzl
Journal:  Transplant Proc       Date:  1995-04       Impact factor: 1.066

Review 7.  The biological basis of and strategies for clinical xenotransplantation.

Authors:  T E Starzl; L A Valdivia; N Murase; A J Demetris; P Fontes; A S Rao; R Manez; I R Marino; S Todo; A W Thomson
Journal:  Immunol Rev       Date:  1994-10       Impact factor: 12.988

Review 8.  Prospects of clinical xenotransplantation.

Authors:  T E Starzl; A Tzakis; J J Fung; S Todo; A J Demetris; R Manez; I R Marino; L Valdivia; N Murase
Journal:  Transplant Proc       Date:  1994-06       Impact factor: 1.066

9.  Targeted Disruption of the β2-Microglobulin Gene Minimizes the Immunogenicity of Human Embryonic Stem Cells.

Authors:  Dachun Wang; Yuan Quan; Qing Yan; John E Morales; Rick A Wetsel
Journal:  Stem Cells Transl Med       Date:  2015-08-18       Impact factor: 6.940

Review 10.  Strategies to overcome the ABO barrier in kidney transplantation.

Authors:  Georg A Böhmig; Andreas M Farkas; Farsad Eskandary; Thomas Wekerle
Journal:  Nat Rev Nephrol       Date:  2015-09-01       Impact factor: 28.314

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.